Related Experiment Videos
New and re-emerging diseases: a dedication to Norman D. Levine
Parasitology Today (Personal Ed.)
|July 20, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Regulatory volume decrease in Trypanosoma cruzi involves amino acid efflux and changes in intracellular calcium.
Molecular and biochemical parasitology·2003
Bisphosphonates as chemotherapeutic agents against trypanosomatid and apicomplexan parasites.
Current drug targets. Infectious disorders·2002
The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization.
The Journal of eukaryotic microbiology·2001
The polyphosphate bodies of Chlamydomonas reinhardtii possess a proton-pumping pyrophosphatase and are similar to acidocalcisomes.
The Journal of biological chemistry·2001
Recent developments in the chemotherapy of Chagas disease.
Current pharmaceutical design·2001
Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.
The Journal of biological chemistry·2001
Immune effector mechanisms in parasitic infections.
Parasitology today (Personal ed.)·2006
Nitric oxide in health and disease.
Parasitology today (Personal ed.)·2006
Infection, oxford general practice series 40.
Parasitology today (Personal ed.)·2006
Parasitism and the platyhelminthes.
Parasitology today (Personal ed.)·2006
The application of attributable risk analysis in helminth epidemiology.
Parasitology today (Personal ed.)·2006
The Search for Novel Malaria Transmission-blocking Targets in the Mosquito Midgut.
Parasitology today (Personal ed.)·2006
Targeting Nonclassical Monocytes via Artificial Cell-Microneedles for Precision Psoriasis Therapy.
Advanced materials (Deerfield Beach, Fla.)·2026
Trends in Meningioma Incidence, Treatment, and Imaging Surveillance.
JAMA oncology·2026
Novel Use of Mavacamten in RAF1-Associated Noonan Syndrome With Hypertrophic Cardiomyopathy.
JACC. Case reports·2026
Functional and Anatomic Outcomes at 12 Months After Switching to Faricimab in Treatment-Recalcitrant Neovascular Age-Related Macular Degeneration.
Journal of vitreoretinal diseases·2026